Differences between low level laser therapy and triamcinolone acetonide kenalog on healing of recurrent aphthous ulceration
|Annals of the College of Medicine, Mosul
|Article 6, Volume 34, Issue 1, June 2008, Pages 35-41 PDF (0 K)
|Tahani A. Al-Sandooq; Mukaram M Al-Waiz; Muhannad A. Kashmoola; Hadeel Salman
|Aim of the Study: The Expected benefit is comparison between new high technical arena low level laser (LLLT) and conventional treatment (triamcinolone acetonide kenalog) and select the most effective and faster method for treatment by assessing clinically the effect of these two methods on healing process of recurrent aphthous ulceration.Subjects, materials and methods: A prospective study of 34 patients, age range 11-45 years, with RAU lesions were divided into: Control group: RAU patients without any treatment.Group I: RAU irradiated with 1.5 Joule laser into two doses (in alternative day).Group II: RAU given triamcinolone acetonide kenalog in orabase daily in two doses. The results obtained account for duration of lesions, size measurement, pain symptoms, and presence of erythema in three visits. Results: Clinically the mean duration of ulcers healing did not differ widely from control group. The pain sensation of RAU that was treated decreased. Statistically, there is no significant difference in the healing process of RAU treated by LLLT and treated by triamcinolone acetonide kenalog.Conclusion: low level laser therapy is biomodulation (biostimulation and bioinhibition).Topical triamcinolone is a glucorticoid that has anti-inflammatory and anti proliferative effects. Clinically they slightly decreased the normal time of healing of this immune dysregulating lesion, but there is no superior difference in clinical effects between these two methods.
|Laser; triamcinolone; aphthous
Article View: 505
PDF Download: 422